Evaluation of CDK12 Protein Expression as a Potential Novel Biomarker for DNA Damage Response–Targeted Therapies in Breast CancerKalnisha Naidoo, Rachael Natrajan, Andrew Tutt et al.|Molecular Cancer Therapeutics|2018Cited by 68
Fine-mapping identifies two additional breast cancer susceptibility loci at 9q31.2Nick Orr, U. Hamann, Frank Dudbridge et al.|Human Molecular Genetics|2015Cited by 48
Functional annotation of the 2q35 breast cancer risk locus implicates a structural variant in influencing activity of a long-range enhancer elementJoseph S. Baxter, Arif B. Ekici, Nichola Johnson et al.|The American Journal of Human Genetics|2021Cited by 12
CYP3A7*1C allele: linking premenopausal oestrone and progesterone levels with risk of hormone receptor-positive breast cancersPeter A. Fasching, Nichola Johnson, Sarah Maguire et al.|British Journal of Cancer|2021Cited by 9
Mo1219 EPIGENETICALLY REGULATED GENE ENHANCERS AS NOVEL RATIONAL THERAPEUTIC TARGETS TO IMPEDE COLORECTAL CANCER PROGRESSIONXinxin Shao, Sudipto Das, Ellen Finnegan et al.|Gastroenterology|2024Cited by 0